Lipids in Signaling and Intracellular Trafficking
Lipid rafts/caveolae flagon designed constructions are opulent in proteins and furthermore lipids example: cholesterol and sphingolipids and have a rare volumes in signal transduction. They assume a part in disease cells advancement, endocytosis and the uptake of pathogenic microorganisms and certain infections. Ponders that have illustrated the part of lipid pontoons in flagging by means of bioreceptor tyrosine kinases and G protein-coupled receptors. The inositol phospholipids frame the basic premise for a mind boggling interchange of flagging reactions created, most regularly, by receptor actuation and bringing about changes in Ca +2 , protein kinase falls, and particle channel/exchanger movement. Phosphatidylinositol (PI) itself is a negligible phospholipid constituent of all eukaryote plasma films.
Understanding the mechanisms of intracellular trafficking and its interaction with other signaling molecules may lead to novel approaches in the treatment of a number of hematologic and other diseases. NIH has invested $127,980 in this specific area in 2015.
- Sphingolipid second messengers
- Second messengers from phosphatidylinositol
- Activators of G-protein coupled receptors
- Activators of nuclear receptors
Related Conference of Lipids in Signaling and Intracellular Trafficking
Lipids in Signaling and Intracellular Trafficking Conference Speakers
Recommended Sessions
- Clinical Lipidology
- Fats - Cardio Metabolic Risks
- Lipid and Lipoprotein Metabolism
- Lipidomics - What’s next?
- Lipids and Bioenergy
- Lipids in Atherosclerosis
- Lipids in Molecular Medicine
- Lipids in Plant Research
- Lipids in Signaling and Intracellular Trafficking
- Lipids: Nutrition and Health
- Obesity and Health
- Plant, Microbial lipids and Essential Oils
- Protein-Lipid & Lipid- Lipid Interactions
- Structural Diversity of Lipids
- Techniques Involved in Lipid Research
Related Journals
Are you interested in
- Biochemistry - Glycobiology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)